PMID- 29892665
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200930
IS  - 2352-5126 (Print)
IS  - 2352-5126 (Electronic)
IS  - 2352-5126 (Linking)
VI  - 4
IP  - 2
DP  - 2018 Mar
TI  - The relevance of a suppressor of fused (SUFU) mutation in the diagnosis and 
      treatment of Gorlin syndrome.
PG  - 196-199
LID - 10.1016/j.jdcr.2017.10.011 [doi]
FAU - Ogden, Taylor
AU  - Ogden T
AD  - Keck School of Medicine at the University of Southern California, Los Angeles, 
      California.
FAU - Higgins, Shauna
AU  - Higgins S
AD  - Keck School of Medicine at the University of Southern California, Los Angeles, 
      California.
FAU - Elbaum, David
AU  - Elbaum D
AD  - Mercy Hospitals of Bakersfield, Bakersfield, California.
AD  - San Joaquin Community Hospital, Bakersfield, California.
FAU - Wysong, Ashley
AU  - Wysong A
AD  - Keck School of Medicine at the University of Southern California, Los Angeles, 
      California.
LA  - eng
PT  - Case Reports
DEP - 20180202
PL  - United States
TA  - JAAD Case Rep
JT  - JAAD case reports
JID - 101665210
PMC - PMC5993552
OTO - NOTNLM
OT  - BCC, basal cell carcinoma
OT  - GS, Gorlin syndrome
OT  - Gorlin syndrome
OT  - Hh, Hedgehog pathway
OT  - PTCH1, patched 1
OT  - SMO, smoothened
OT  - SUFU, suppressor of fused
OT  - basal cell carcinoma
OT  - irradiation therapy
OT  - medulloblastoma
EDAT- 2018/06/13 06:00
MHDA- 2018/06/13 06:01
PMCR- 2018/02/02
CRDT- 2018/06/13 06:00
PHST- 2018/06/13 06:00 [entrez]
PHST- 2018/06/13 06:00 [pubmed]
PHST- 2018/06/13 06:01 [medline]
PHST- 2018/02/02 00:00 [pmc-release]
AID - S2352-5126(17)30263-1 [pii]
AID - 10.1016/j.jdcr.2017.10.011 [doi]
PST - epublish
SO  - JAAD Case Rep. 2018 Feb 2;4(2):196-199. doi: 10.1016/j.jdcr.2017.10.011. 
      eCollection 2018 Mar.